title: [The Nadis cohort: 6236 HIV-infected patients followed up in French university hospitals].
abstract: OBJECTIVE
  The Nadis electronic medical patient record allows real time constitution of a database including the clinical, therapeutic, biological, and epidemiological features of HIV-positive patients.
  
  
  METHODS
  Data concerning HIV-infected patients followed-up in 6 French University Hospitals was collected. Data quality was assessed on a regular basis in each center.
  
  
  RESULTS
  The 6 first University hospitals using Nadis agreed to group their data on March 15, 2004, concerning 6236 patients having consulted at least once in the previous year. Among these, 29% were female patients, 80% were under treatment on March 15, 2004, 9% were off treatment, 29% were co-infected by hepatitis B or C virus, 57% had an undetectable viral load, 15% of the treated patients were in a worrying immunovirological situation, 358 were diagnosed HIV-positive in 2003. 35% of these "new patients" were women, the mode of infection was sexual in 80%, 45% were under treatment on March 15, 04. This recent data allowed us to have an accurate assessment of this population's management in 2004.
authors.affiliation: La Pitié Salpêtrière, France.
authors.forename: R
authors.initials: R
authors.lastname: Agher
authors.forename: C
authors.initials: C
authors.lastname: Duvivier
authors.forename: C
authors.initials: C
authors.lastname: Katlama
authors.forename: Y
authors.initials: Y
authors.lastname: Gérard
authors.forename: Y
authors.initials: Y
authors.lastname: Yazdanpanah
authors.forename: E
authors.initials: E
authors.lastname: Billaud
authors.forename: T
authors.initials: T
authors.lastname: Jovelin
authors.forename: F
authors.initials: F
authors.lastname: Raffi
authors.forename: P
authors.initials: P
authors.lastname: Enel
authors.forename: I
authors.initials: I
authors.lastname: Poizot-Martin
authors.forename: P
authors.initials: P
authors.lastname: Puglièse
authors.forename: P
authors.initials: P
authors.lastname: Dellamonica
authors.forename: M
authors.initials: M
authors.lastname: Barone
authors.forename: L
authors.initials: L
authors.lastname: Cuzin
authors.forename: B
authors.initials: B
authors.lastname: Marchou
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D015331:Cohort Studies; D015897:Comorbidity; D016208:Databases, Factual; D018562:Disease Transmission, Infectious; D005260:Female; D005500:Follow-Up Studies; D005602:France / Q000453:epidemiology; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000635:transmission; D006509:Hepatitis B / Q000453:epidemiology; D006526:Hepatitis C / Q000453:epidemiology; D006785:Hospitals, University / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D016347:Medical Records Systems, Computerized; D008875:Middle Aged; D011786:Quality Control; D012725:Sexual Behavior; D015819:Substance Abuse, Intravenous / Q000453:epidemiology; D065227:Transfusion Reaction; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents